Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Food or edible as carrier for pharmaceutical
Reexamination Certificate
2005-12-20
2005-12-20
Naff, David M. (Department: 1651)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Food or edible as carrier for pharmaceutical
C424S093400, C424S093700, C424S520000, C424S538000, C424S547000, C426S002000, C426S006000, C426S805000
Reexamination Certificate
active
06977084
ABSTRACT:
A pet food product and process for producing the pet food product for use in maintenance of healthy joints and alleviation of arthritic symptoms in companion animals, the pet food comprising an effective amount of an active extract ofPerna canaliculus. The extract can be either a powder or lipid extract. Preferably in an amount that provides for a dosage range of generally 0.18 to 114 mg of a powder extract/kg of body weight/day in a companion animal or an amount of generally 1.5 to 1000 mg of a powder extract ofPerna canaliculusper 400 kcal of pet food product.
REFERENCES:
patent: 4455298 (1984-06-01), McFarlane et al.
patent: 4801453 (1989-01-01), Kosuge et al.
patent: 5364845 (1994-11-01), Henderson
patent: 5587363 (1996-12-01), Henderson
patent: 5843919 (1998-12-01), Burger
patent: 6083536 (2000-07-01), Macrides et al.
patent: 0010061 (1979-09-01), None
patent: 0982034 (2000-03-01), None
patent: 03080079 (1989-08-01), None
patent: 270754 (1997-08-01), None
patent: 2017439 (1994-08-01), None
patent: 2097982 (1997-12-01), None
patent: PC-94/22453 (1994-10-01), None
patent: PC-96/05164 (1996-02-01), None
patent: PC-97/09992 (1997-03-01), None
patent: PC-97/21434 (1997-06-01), None
Healtheries of New Zealand Limited First Amended Notice of Opposition Jul. 8, 2004 to Grant of Patent Search (Section 21), In the matter of New Zealand Patent Application No. 514389 in the name of Kal Kan Foods, Inc. and in the matter of an opposition thereto by Healtheries of New Zealand Ltd., New Zealand Patent Office.
Waitaki Biosciences International Limited First Amended Notice of Opposition Jul. 8, 2004 to Grant of Patent Search (Section 21), In the matter of New Zealand Patent Application No. 514389 in the name of Kal Kan Foods, Inc. and in the matter of an opposition therto by Healtheries of New Zealand Ltd., New Zealand Patent Office.
Healtheries of New Zealand Limited First Amended Statement of Case (Jul. 8, 2004), In the matter of New Zealand Patent Application No. 514389 in the name of Kal Kan Foods, Inc. and in the matter of an opposition thereto by Healtheries of New Zealand Ltd., New Zealand Patent Office.
Affirmation of John Eric Croft, In the matter of New Zealand Patent Application No. 514389 in the name of Kal Kan Foods, Inc. and in the matter of an opposition thereto by Healtheries of New Zealand Ltd., New Zealand Patent Office.
Waitaki Biosciences International Limited First Amended Statement of Case (Jul. 8, 2004), In the matter of New Zealand Patent Application No. 514389 in the name of Kal Kan Foods, Inc. and in the matter of an opposition thereto by Healtheries of New Zealand Ltd., New Zealand Patent Office.
Letter from AJ Park Forwarding First Amended Statement of Case and First Amended Notice of Opposition from Healtheries of New Zealand Limited and Waitaki Biosciences International Limited dated Jul. 8, 2004.
Waitaki Biosciences International Limited, “Statement of Case,” In the matter of an application for Letters Patent No. 514389 in the name of Kal Kan Foods, Inc. and in the matter of a Section 21 pregrant opposition theretoby Waitaki Biosciences Intenational Ltd, New Zealand Patent Office.
Healtheries of New Zealand Limited, “Statement of Case,” In the matter of application for Letters of Patent No. 514389 in the name of Kal Kan Foods, Inc. and in the matter of a Section 21 pregrant opposition thereto by Healtheries of New Zealand Ltd., New Zealand Patent Office.
Kal Kan Foods, Inc. “Counterstatement,” In the matter of New Zealand Patent Application No. 514389 in the name of Kal Kan Foods, Inc. and in the matter of an opposition thereto by Healtheries of New Zealand Ltd., New Zealand Patent Office.
Kal Kan Foods, Inc. “Counterstatement,” In the matter of New Zealand Patent Application No. 514389 in the name of Kal Kan Foods, Inc. and in the matter of an opposition thereto by Waitaki Biosciences International Ltd, New Zealand Patent Office.
McFarlane Laboratories NZ Ltd. Product Label—McFarlane SF6 The Seatone Formula for Horses.
Chassot Product Information for “Bihorsan” Pellets for horses.
Chassot product information for “Cartiflex”.
Ford, G.R. “Experience with SF6 at Footbridge” Jul. 14, 1995.
Animal Health Services Centre—Massey University, “Final report on the Efficacy of Green-Lipped Mussel Extract in the Management of Degenerative Joint Disease in Dogs,” Study No. AHSC-75353, Sep. 1999.
Chassot product information for CHASSOTON Granules 4%.
Gibson et al, “Perna canaliculusin the treatment of arthritis,” Practitioner 224, No. 1347, pp. 995-960 (Sep. 1980).
Orima et al, “Clinical Effects of the extract of the New Zealand Green- Lipped Mussel on Dogs and Cats with Joint Diseases,” Small Animal Veterinarys Clinic vol. 17, No. 1, Jan. 1998.
Croft, John E. The New Zealand Green-Lipped Mussel (3 ed., Thorsons, London, 1995) pp. 38-50, 57-85, 122-122.
McFarlane Laboratories SF4 & SF6—Scientific Information—released by McFarlane Laboratories.
Welsner, Christof of Masterhorse Service, letter to Waitaki Biosciences International, Ltd, Jun. 4, 1996.
Mussels bring Arthritis Relief, Veterinary Practice Jan. 7, 1985.
McFarlane Product Information for Green Liped Mussel Extract.
Product Information for McFarlane SF6 The Seatone Formula for Horses.
McFarlane Product Label for SF4 for Cats—Green Lipped Mussel Extract.
McFarlane Product Label for SP4 for Dogs—Green Lipped Mussel Extract.
Product Information in respect of CANOSAN concentrate and pellets for dogs.
Miller et al, “Evaluation of the Effect of Seatone Administration on Cell-Mediated Immune Mechanisms Determined Using in Vitro and in Vivo Analysis of T Lymphocyte Function,”.
Chassot Product Information for CANOSAN Concentrate Granules.
Chassot Product Information for CANOSAN Pellets.
European Search Report.
Miller, Thomas, et al.; In vivo evidence for prostaglandin inhibitory activity in New Zealand green-lipped mussel extract; New Zealand Med. J.; pp 355-357, Jun. 13, 1984.
Kosuge, Takuo, et al.; Isolation of an Anti-histaminic Substance from Green-Lipped Mussel (perna canaliculus); Chem. Pharm. Bull., vol. 34 (11): 4825-4828, 1986.
McFarlane, S. J.; Green Mussel and Rheumatoid arthritis; New Zealand Med. J., p. 569, Jun. 25, 1975.
Miller, T. E.; Anti-Inflammatory effects of mussel extracts; New Zealand Med. J., pp. 23-24, Jan. 14, 1981.
COSEQUIN* and COSEQUIN* DS Advertisement.
Bennett, David, et al.; Textbook of Veterinary Internal Medicine: Diseases of the Dog and Cat: Chapter 149 Joint Diseases of Dogs and Cats; pp. 2032-2075.
Korthauer, Walter, et al.; Behandlung deformierender Arthropathien beim Diensthund mit einem neuen Glykosaminoglykanpraparat; Kilentierpraxis 37, pp. 467-478, Jan. 1992.
Volker, Dianne, et al.; Dietary N-3 Fatty Acid Supplementation in Rheumatoid Arthritis—Mechanisms, Clinical Outcomes, Controversies, and Future Directions; J. Clin. Biochem. Nutr. 20, pp. 83-97, 1996.
Kremer, Joel M., et al.; Dietary Fish Oil and Olive Oil Supplementation in Patients with Rheumatoid Arthritis—Clinical and Immunological Effects; Arthritis and Rheumatism 33 (6), pp. 810-820, Jun. 1990.
Winter, Charles A., et al.; Carrageenin-Induced Edema in Hind Paw of the Rat as an Assay for Anti-inflammatory Drugs; Merck Institute for Therapeutic Research, pp. 544-547, West Point, PA.
Cullen, J. C., et al.; The Effectof Dried Mussel Extract on an Induced Polyarthritis in Rats; New Zealand Med. J., pp. 260-261, Mar. 12, 1975.
Miller, Thomas E., et al.; The anti-inflammatory activity ofPerna canaliculus(NZ green lipped mussel); New Zealand Med. J. 97; 667; pp. 187-193 (Sep. 10, 1980).
Rainsford, K. D., et al.; Gastroprotective and Anti-inflammatory Properties of Green Lipped Mussel (perna canaliculus) Preparation; Arzneim.-Forsch./Drug Res. 30 (II) Nr. 12, pp. 2128-2132, 1980.
Whitehouse, M. W., et al.; Anti-Inflammatory Activity of a Lipid Fraction (Lyprinol) from the NZ Green-Lipped Mussel; Inflammopharmacology 5:
Bektash Roger
Bierer Tiffany L.
Blackwood Graeme
Bui Linh M.
Hodge Jason
Fulbright & Jaworski L.L.P.
Naff David M.
Ware Deborah K.
LandOfFree
Pet food containing Perna canaliculus for maintenance of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pet food containing Perna canaliculus for maintenance of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pet food containing Perna canaliculus for maintenance of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3494405